Capstone Investment Advisors, LLC Cogent Biosciences, Inc. Transaction History

Capstone Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$4.06 - $10.08 $164,434 - $408,250	40,501 New	40,501 $238,000
Q4 2021 Feb 11, 2022	SELL	$7.51 - $10.81 $97,089 - $139,751	-12,928 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.99 - $9.14 $77,438 - $118,161	12,928 New	12,928 $108,000
Q1 2021 May 17, 2021	SELL	$7.47 - $12.34 $108,815 - $179,756	-14,567 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.04 - $13.01 $131,685 - $189,516	14,567 New	14,567 $164,000

170

113M

56.7K

40.4K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $585M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.